51 Biggest Movers From Yesterday

Gainers

• Amarin Corporation plc AMRN shares surged 314.72 percent to close at $12.40 on Monday after the company's REDUCE-IT cardiovascular study of Vascepa in LDL-C patients met its primary endpoint.
• SAExploration Holdings, Inc. SAEX shares jumped 284.34 percent to close at $28.71.
• Jones Energy, Inc. JONE gained 36.12 percent to close at $6.52. Jones Energy regained compliance with NYSE continued listing requirements.
• Intrexon Corporation XON gained 31.52 percent to close at $19.07 after announcing advances in development of its microbial platform to produce cannabinoids for medical uses.
• Apollo Medical Holdings, Inc. AMEH gained 18.66 percent to close at $19.71.
• Akcea Therapeutics, Inc. AKCA climbed 18.23 percent to close at $33.08 after the company earlier reported data from a Phase 2 study of AKCEA-APO(a)-LRx in patients with cardiovascular disease.
• California Resources Corporation CRC shares gained 17.63 percent to close at $46.58.
• AcelRx Pharmaceuticals, Inc. ACRX rose 16.46 percent to close at $4.60.
• Mexco Energy Corporation MXC gained 15.82 percent to close at $5.71 on Monday.
• Achieve Life Sciences, Inc. ACHV shares rose 15.66 percent to close at $2.88.
• LiveXLive Media, Inc. LIVX gained 15.38 percent to close at $4.05.
• Innovate Biopharmaceuticals, Inc. INNT shares rose 14.7 percent to close at $7.96.
• Seabridge Gold Inc. SA shares climbed 14.16 percent to close at $12.90.
• Conatus Pharmaceuticals Inc. CNAT gained 13.66 percent to close at $6.49.
• Applied Genetic Technologies Corporation AGTC climbed 13.64 percent to close at $5.00. Wells Fargo upgraded Applied Genetic Technologies from Market Perform to Outperform.
• Geron Corporation GERN gained 13.55 percent to close at $6.20.
• Adamis Pharmaceuticals Corporation ADMP shares rose 12.9 percent to close at $3.50.
• Idera Pharmaceuticals, Inc. IDRA gained 12.78 percent to close at $9.53. Barclays initiated coverage on Idera Pharmaceuticals with an Overweight rating.
• Medigus Ltd. MDGS surged 12.7 percent to close at $3.55.
• Y-mAbs Therapeutics, Inc. YMAB gained 12.37 percent to close at $26.97.
• Fate Therapeutics, Inc. FATE rose 11.74 percent to close at $16.28.
• AzurRx BioPharma Inc AZRX rose 11.32 percent to close at $2.95 after the company's Phase IIa trial of MS1819-SD for exocrine pancreatic insufficiency met its primary endpoints.
• AnaptysBio, Inc. ANAB rose 9.86 percent to close at $101.95. AnaptysBio reported 'positive' topline data from Phase 2a proof-of-concept clinical trial of etokimab in severe eosinophilic asthma.
• Xenetic Biosciences, Inc. XBIO shares rose 9.31 percent to close at $3.64.
• EP Energy Corporation EPE gained 8.7 percent to close at $2.25.
• Aridis Pharmaceuticals, Inc. ARDS shares rose 7.99 percent to close at $12.97 after the company reported patent issuance covering two product candidates, AR-201 and AR-401.
• ENDRA Life Sciences Inc. NDRA shares rose 7.85 percent to close at $3.57.
• Immutep Limited IMMP rose 6.98 percent to close at $3.22 after announcing a clinical trial collaboration and supply agreement with Merck KGaA, Darmstadt, Germany and Pfizer Inc.
• Randgold Resources Limited GOLD rose 6.62 percent to close at $68.14 after the company announced plans to merge with Barrick Gold Corp ABX in a deal worth $18.3 billion.
• Alexion Pharmaceuticals, Inc. ALXN shares gained 5.34 percent to close at $128.51 after the company disclosed that Phase 3 study of soliris met its primary endpoint.

Losers

• Altimmune, Inc. ALT dipped 46.93 percent to close at $13.90 on Monday. Altimunne reported a $4.9 million common stock offering. Altimmune reported that it has been awarded additional $2.5 million in BARDA funding to support nasoshield development.
• Astrotech Corporation ASTC fell 40.43 percent to close at $3.33. Astrotech posted a Q4 loss of $0.63 per share on sales of $45,000.
• Cool Holdings, Inc. AWSM shares dropped 36.37 percent to close at $12.09 on Monday after surging 80.95 percent on Friday.
• New Age Beverages Corporation NBEV shares dropped 35.61 percent to close at $3.96 after reporting a $50 million at-the-market offering.
• Spectrum Pharmaceuticals, Inc. SPPI dipped 22.66 percent to close at $16.52. Spectrum Pharmaceuticals disclosed release of updated poziotinib data from MD Anderson Phase 2 study in non-small cell lung cancer patients.
• Tilray, Inc. TLRY shares declined 19.11 percent to close at $99.50 after dropping 30.25 percent on Friday.
• Nightstar Therapeutics plc NITE dropped 16.43 percent to close at $21.31.
• Qutoutiao Inc. QTT shares fell 15.07 percent to close at $7.27.
• Therapix Biosciences Ltd. TRPX dipped 14.29 percent to close at $4.50.
• Surface Oncology, Inc. SURF shares fell 13.24 percent to close at $10.42.
• JAKKS Pacific, Inc. JAKK shares dropped 12.07 percent to close at $2.55.
• Leju Holdings Limited LEJU shares fell 11.47 percent to close at $1.93 on Monday.
• Reed's, Inc. REED shares dropped 11.11 percent to close at $3.20.
• Rosehill Resources Inc. ROSE tumbled 10.56 percent to close at $7.20 after reporting a 6.15 million share offering.
• India Globalization Capital, Inc. IGC fell 10.34 percent to close at $2.60 on Monday after rising 34.88 percent on Friday. India Globalization Capital filed prospectus for sale of up to $20 million in common stock, warrants and units.
• PPDAI Group Inc. PPDF fell 9.24 percent to close at $5.99.
• Aurora Mobile Limited JG shares dipped 8.74 percent to close at $7.52.
• Nutanix, Inc. NTNX declined 8.72 percent to close at $42.40. Susquehanna downgraded Nutanix from Neutral to Negative.
• Chuy's Holdings, Inc. CHUY dipped 8.24 percent to close at $25.05. BMO Capital downgraded Chuy's from Market Perform to Underperform and lowered the price target from $28 to $23.
• Michael Kors Holdings Limited KORS dropped 8.23 percent to close at $66.71 following earlier reports the company is nearing a deal to acquire Versace for $2 billion.
• Comcast Corporation CMCSA dropped 5.99 percent to close at $35.63 following the company's $39 billion offer for Sky. Analysts at Oppenheimer And Moffett Nathanson downgraded the stock.